Oral Contraceptives and Myocardial Infarction
نویسندگان
چکیده
منابع مشابه
Oral contraceptives and myocardial infarction.
Between January 1970 and December 1972 22 women aged between 31 and 45 years were admitted to the coronary care unit with acute myocardial infarction and six of these (27%) had been taking oral contraceptives. There were nine women aged 40 or less and five of them (55%) had been on oral contraceptives while three of the other four had been sterilized by tubal interruption.Both these figures of ...
متن کاملMyocardial infarction and oral contraceptives.
During 1968-I972, 4 women of4I years or less were admitted with a myocardial infarction. Three ofthem had been taking oral contraceptives, all were moderate to heavy smokers, and the fathers of all of them had had a myocardial infarct after the age of 5o years. One had slight hypertension while using oral contraceptives and her serum cholesterol and lipids were increased. Details of all 3 cases...
متن کاملOral contraceptives and death from myocardial infarction.
We investigated 219 deaths from myocardial infarction in women under the age of 50. Their histories were compared with those of living age-matched controls selected from the same general practices. The frequency of use of oral contraceptives during the month before death was significantly greater in the group with infarction than during the corresponding month in the control group and the avera...
متن کاملOral contraceptives and the risk of myocardial infarction.
The relation of oral contraceptive use to the risk of myocardial infarction was assessed in a hospital-based case-control study of women aged 25-64 years conducted from 1985 to 1988 in New England; 910 women with first myocardial infarctions were compared with 1,760 control women. Oral contraceptive use, after discontinuation, was not associated with an increased risk of myocardial infarction, ...
متن کاملOral contraceptives and cardiovascular disease: emerging evidence on potential associations with angina, myocardial infarction and stroke.
Associations between combined estrogen/progestin oral contraceptives (OCs) and cardiovascular disease (CVD) have long been the focus of considerable concern. Initial, epidemiologic studies demonstrated increased risks of potential complications including deep venous thrombosis/pulmonary embolism, myocardial infarction and stroke. While the studies regarding venous thromboembolism consistently d...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: BMJ
سال: 1973
ISSN: 0959-8138,1468-5833
DOI: 10.1136/bmj.3.5877.428